Switch to:

BridgeBio Pharma EV-to-EBIT

: -19.10 (As of Today)
View and export this data going back to 2019. Start your Free Trial

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, BridgeBio Pharma's Enterprise Value is $8,133.31 Mil. BridgeBio Pharma's EBIT for the trailing twelve months (TTM) ended in Sep. 2020 was $-425.88 Mil. Therefore, BridgeBio Pharma's EV-to-EBIT for today is -19.10.

NAS:BBIO' s EV-to-EBIT Range Over the Past 10 Years
Min: -19.3   Med: -10.6   Max: -7
Current: -19.1

-19.3
-7

During the past 3 years, the highest EV-to-EBIT of BridgeBio Pharma was -7.00. The lowest was -19.30. And the median was -10.60.

NAS:BBIO's EV-to-EBIT is ranked lower than
99.99% of the 245 Companies
in the Biotechnology industry.

( Industry Median: 36.49 vs. NAS:BBIO: -19.10 )

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. BridgeBio Pharma's Enterprise Value for the quarter that ended in Sep. 2020 was $4,258.79 Mil. BridgeBio Pharma's EBIT for the trailing twelve months (TTM) ended in Sep. 2020 was $-425.88 Mil. BridgeBio Pharma's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2020 was -10.00%.


BridgeBio Pharma EV-to-EBIT Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

BridgeBio Pharma Annual Data
Dec17 Dec18 Dec19
EV-to-EBIT 0.00 0.00 -14.10

BridgeBio Pharma Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20
EV-to-EBIT Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -8.60 -14.10 -9.78 0.00 0.00

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


BridgeBio Pharma EV-to-EBIT Distribution

* The bar in red indicates where BridgeBio Pharma's EV-to-EBIT falls into.



BridgeBio Pharma EV-to-EBIT Calculation

BridgeBio Pharma's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=8133.314/-425.881
=-19.10

BridgeBio Pharma's current Enterprise Value is $8,133.31 Mil.
BridgeBio Pharma's EBIT for the trailing twelve months (TTM) ended in Sep. 2020 was -81.111 (Dec. 2019 ) + -100.072 (Mar. 2020 ) + -125.46 (Jun. 2020 ) + -119.238 (Sep. 2020 ) = $-425.88 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


BridgeBio Pharma  (NAS:BBIO) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

BridgeBio Pharma's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2020 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Sep. 2020 ) =EBIT / Enterprise Value (Q: Sep. 2020 )
=-425.881/4258.78636
=-10.00 %

BridgeBio Pharma's Enterprise Value for the quarter that ended in Sep. 2020 was $4,258.79 Mil.
BridgeBio Pharma's EBIT for the trailing twelve months (TTM) ended in Sep. 2020 was -81.111 (Dec. 2019 ) + -100.072 (Mar. 2020 ) + -125.46 (Jun. 2020 ) + -119.238 (Sep. 2020 ) = $-425.88 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


BridgeBio Pharma EV-to-EBIT Related Terms


BridgeBio Pharma EV-to-EBIT Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)